A Milestone in Sports-Driven Philanthropy
The National Hockey League, the NHL Players’ Association and the V Foundation for Cancer Research announced that the 2025‑26 season produced a record $9.1 million for Hockey Fights Cancer, a campaign that has now exceeded $53 million in total contributions since its inception in 1998.
The latest haul will be directed toward cancer research across the league’s 22 North American markets, supporting both pediatric and adult oncology projects. The V Foundation said the funds will underwrite 42 research grants to date, with additional awards expected from this season’s donations.
Partner Support Fuels Innovation
Pharmaceutical leader AstraZeneca pledged $1.1 million, while automotive manufacturer Hyundai and its Canadian partners contributed $1 million earmarked for pediatric cancer research. The nicotine‑replacement product Nicorette added $126,000 to the total, underscoring a multi‑industry commitment to the cause.
Beyond national research, individual NHL clubs have raised more than $3.2 million for local cancer‑related charities, amplifying the campaign’s community impact. The American Cancer Society and Canadian Cancer Society together collected over $1 million through the HFC Assist program, further extending the financial reach of the initiative.
The Foligno Face‑Off campaign in Minnesota, which focuses on breast‑cancer research, generated more than $200,000, and the American Hockey League contributed $18,500 to the effort this season, illustrating the depth of grassroots involvement across the sport.
Looking ahead, the V Foundation plans to expand its research portfolio into six new NHL markets, building on its presence in 22 of the league’s 32 franchises. The infusion of capital is expected to accelerate breakthroughs that benefit patients nationwide, reinforcing the unique synergy between professional hockey and charitable giving.